Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

6-Bromoxytryptophan

    • Product Name 6-Bromoxytryptophan
    • Alias 6-Bromo-Oxitrp
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    180872

    Chemical Name 6-Bromoxytryptophan
    Molecular Formula C11H11BrN2O2
    Molecular Weight 283.12 g/mol
    Cas Number 164860-69-1
    Iupac Name 2-amino-3-(6-bromo-1H-indol-3-yl)propanoic acid
    Appearance off-white to light yellow solid
    Solubility soluble in water and DMSO
    Storage Temperature 2-8°C (refrigerated)
    Purity ≥98% (HPLC)
    Smiles C1=CC2=C(C=C1Br)NC=C2CC(C(=O)O)N

    As an accredited 6-Bromoxytryptophan factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing
    Shipping
    Storage
    Application of 6-Bromoxytryptophan

    Applications of 6-Bromoxytryptophan in Industrial Manufacturing

    As a specialist manufacturer of 6-Bromoxytryptophan, we supply this advanced amino acid derivative for key industrial sectors with strict regulatory and technical requirements. The following applications detail real downstream integration, compliance demands, and formulating practices across production environments where this specialty intermediate delivers unique functional and molecular roles.

    1. Active Pharmaceutical Ingredient (API) Synthesis for CNS Drug Discovery

    Researchers and pharmaceutical manufacturers incorporate 6-Bromoxytryptophan into targeted synthesis routes for developing new central nervous system (CNS) therapeutics. The distinct brominated position on the indole ring enables medicinal chemists to generate serotonin receptor ligands and neuroprotective compounds with modified biological profiles. Typically, the material enters scaffold modification processes at the heteroaromatic building block stage, allowing downstream coupling, alkylation, or peptide extension steps. Adherence to pharmacopoeia-grade starting material specifications is enforced throughout GMP environments to guarantee traceability within the API development pipeline.

    Industry compliance standards

    • International Council for Harmonisation (ICH Q7) GMP for APIs
    • United States Pharmacopeia (USP) General Chapter <1070> on impurities
    • European Pharmacopoeia (Ph. Eur.) monographs for precursor qualification
    • ISO 9001:2015 Quality Management for regulated synthesis

    Typical usage ratio

    • 0.8–1.2 molar equivalents, based on target scaffold; adjusted according to desired substitution degree and downstream isolation yield optimization

    Downstream process integration

    • Early-stage input for heterocycle construction, brominated indole pathway modifications, and as a coupling partner in automated solid-phase or solution-phase peptide synthesis

    Final product types

    • Selective serotonin agonists and antagonists
    • Neuroactive experimental drug candidates
    • Peptide-derived CNS API scaffolds for clinical research

    2. Analytical Standards and Metabolite Reference Compounds

    Chemical analysis laboratories and pharmaceutical quality control divisions require pure 6-Bromoxytryptophan as a reference material for developing LC-MS/MS, NMR, and HPLC analytical methods. Its defined molecular weight and functionality enable precise metabolite tracing, method validation for impurity profiling, and calibration standards for novel brominated tryptophan derivatives in biological samples. Production for this segment demands documentation of trace-level contaminant control and certified reference material (CRM) protocols per international guidelines for analytical traceability.

    Industry compliance standards

    • ISO 17034:2016 General requirements for the competence of reference material producers
    • ISO/IEC 17025:2017 Laboratory competence for calibration and testing
    • FDA Guidance for Industry: Analytical Procedures and Methods Validation
    • USP General Chapter <621> Chromatography method standards

    Typical usage ratio

    • 1–10 µg/mL in working analytical solutions; variation according to instrument calibration curve requirements and matrix complexity

    Downstream process integration

    • Preparation of working and stock reference solutions for baseline chromatographic peaks, metabolite comparison, and impurity tracking during drug substance and biological sample testing workflows

    Final product types

    • CRM ampoules and powder vials for laboratory reference libraries
    • Standardized comparison kits for metabolite structural confirmation
    • Control spike solutions for pharmacokinetic and toxicology studies

    3. Fine Chemical Intermediate for Biocatalytic Tryptophan Derivative Synthesis

    Producers of advanced fine chemicals and specialty amino acids leverage 6-Bromoxytryptophan as a strategic substrate in enzymatic biotransformation platforms. Enzyme-catalyzed modifications capitalize on its unique bromine moiety, opening selectivity for downstream halogen exchange or functional group insertion. Industrial fermentation facilities utilize it for expanding derivatization libraries relevant to biotechnological reagents, selectively feeding 6-brominated tryptophan into microorganism cultures or in vitro enzymatic reactors.

    Industry compliance standards

    • ISO 22716:2007 (GMP for fine chemical production)
    • REACH Regulation (EC) No 1907/2006 for chemical control
    • FSSC 22000 for biotechnological processing sites when supplying food-grade intermediates
    • Local environmental compliance and effluent disposal certifications

    Typical usage ratio

    • 0.5–2% (w/v) in fermentation media or batch reactor; set according to biotransformation efficiency and microbiological conversion rates

    Downstream process integration

    • Direct substrate charging into enzyme bioreactors, phase feeding in controlled fermenters, or as an intermediate in one-pot halogen exchange reactions leading to specialty amino acid analogues

    Final product types

    • Hydroxy-, methyl-, or fluoro-substituted tryptophan analogues
    • Customized indole derivatives for research reagents
    • Chiral building blocks for pharmaceutical and agrochemical development

    4. Precursor for Radiolabeled PET Tracers in Medical Imaging

    Radiochemistry and nuclear medicine facilities source 6-Bromoxytryptophan as a functionalized precursor for synthesis of radiolabeled positron emission tomography (PET) tracers. The brominated position serves as a reactive site for nucleophilic substitution with isotopically labeled fluorine or iodine under no-carrier-added conditions. Precision synthesis protocols demand documented impurity profiles and radionuclide compatibility assessments, while manufacturing workflows adhere to strict medical tracer production standards.

    Industry compliance standards

    • USP General Chapter <823>: Radiopharmaceuticals for Positron Emission Tomography
    • 21 CFR Part 212: cGMP for PET drugs
    • European Pharmacopoeia Monograph 07/2014:2894 for PET radiopharmaceutical precursors
    • Radiation safety licensing (local regulatory authority)

    Typical usage ratio

    • 0.05–0.2 mmol per batch; adjusted to specific tracer labeling stoichiometry, balancing radioisotope yield and decay rates

    Downstream process integration

    • Precursor feed into automated synthesis modules for halogen exchange, nucleophilic labeling, and final purification steps in PET tracer cassette setups

    Final product types

    • 18F- or 123I-labeled tryptophan analogues for PET neuroimaging
    • Experimental imaging agents for CNS receptor binding studies
    • Quality control samples for radiochemical purity and stability testing
    Free Quote

    Competitive 6-Bromoxytryptophan prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    6-Bromoxytryptophan: Exploring a Valuable Tryptophan Derivative

    A New Look at an Evolving Compound

    Watching the evolution of fine chemical tools over the years has highlighted the growing value of thoughtfully designed tryptophan derivatives. 6-Bromoxytryptophan stands out in this lineage. In laboratories and research centers that focus on structure–activity relationships or metabolic pathway mapping, such compounds act like clever probes, opening new routes to discovery. Not long ago, adding a halogen atom to an amino acid was rare and ambitious, but current synthetic chemistry has made these compounds much more accessible. Among all brominated analogs of standard amino acids, 6-Bromoxytryptophan brings a special flavor to work involving indole ring manipulation and site-specific labeling.

    What Sets 6-Bromoxytryptophan Apart?

    Researchers often reach for tryptophan variants while looking for better control in peptide synthesis or as building blocks for molecules that mimic complex natural products. Regular tryptophan already fuels advances in neuroscience and pharmacology, yet subtle tweaks—like brominating the six-position on the indole ring—can dramatically shift the behavior of a parent molecule. The presence of a bromine atom in this specific position draws attention for modifying electron distribution in the heterocycle. This gives medicinal chemists a chance to test binding site hypotheses or follow metabolic fates in cell pathways. In my own experience working alongside colleagues in peptide chemistry, the excitement over this type of compound comes from the way it helps answer questions that standard tryptophan simply can’t reach.

    The unique model of 6-Bromoxytryptophan available today often carries a high chemical purity, usually above 98 percent, supported by careful chromatographic verification. The process that brings it to the shelf builds on modern solid-phase synthetic techniques, so it arrives as a free-flowing powder, generally stable when stored at room temperature in dry conditions. This is far removed from previous decades, when custom amino acid analogs could take weeks or months to synthesize to the level demanded by today’s research labs.

    Those who have confronted challenges in labeling proteins or developing fluorescent markers know the frustration of losing activity or expression with ordinary chemical modifications. 6-Bromoxytryptophan avoids some common pitfalls by holding onto the backbone structure of tryptophan while introducing a distinctive tag. This lets researchers track protein folding, probe receptor-ligand interaction, or launch cross-coupling reactions through the bromine site without heavy disruption to peptide activity.

    Where 6-Bromoxytryptophan Finds Its Role

    Academic biochemists may turn to 6-Bromoxytryptophan when studying how proteins interact with ligands or break down inside cells. Its use in such settings, I’ve seen, often begins with the curiosity to faithfully mimic native protein environments even as new residues are introduced. By replacing natural tryptophan with its brominated analogue, researchers can detect position-specific modifications by NMR or mass spectrometry. Analytical reliability improves, not just because of the extra atomic mass, but through signal enhancement in labeling or imaging applications.

    Pharmaceutical research also gets a boost from this derivative. It can help teams explore druggability at particular receptor sites, especially those that interact with serotonin or melatonin pathways. Given that many central nervous system drugs rely on tryptophan or indole scaffolds, 6-Bromoxytryptophan becomes a vital test-case in preclinical work. Its larger atomic profile compared to native hydrogen or fluorine introduces new steric effects at the site of action, guaranteeing more diverse data from structure–activity relationship studies. Further, teams in synthetic biology are increasingly swapping natural amino acids for halogenated versions like this to endow proteins with desirable properties—think improved resistance to enzymatic breakdown or the ability to host site-specific modifications after biosynthesis.

    In chemical biology, specifically, the appeal of 6-Bromoxytryptophan extends to photo-crosslinking and click-chemistry. The bromine atom can act as a chemical handle for Suzuki, Sonogashira, or Stille coupling, opening new vistas for attaching probes, dyes, or other biomolecules. These coupling reactions, which rely on palladium catalysis, benefit from bromine’s balance between reactivity and stability. I remember working on a collaborative project aimed at tracing protein-protein interactions in living cells—using 6-Bromoxytryptophan made a once-complex labeling protocol not only more reliable but gentler, resulting in cleaner, more interpretable data.

    Differences That Matter in Practice

    Trying to shortlist a tryptophan analogue for a new project can feel daunting. With so many chemically altered amino acids on the market—think fluorinated, nitrated, or methylated versions—many share overlapping features. Yet 6-Bromoxytryptophan sets itself apart on several levels. It is less prone to rapid oxidative breakdown compared to nitroanalogues or other halogenated residues in the indole ring—for instance, 5-bromo or 7-bromo tryptophan derivatives. The position of bromine at carbon six often creates synthetic opportunities that are harder to tap with substitutions elsewhere on the indole structure. The usual trade-off with more reactive analogs—instability under ambient lab conditions—doesn’t come up here in the same way.

    There’s also an advantage in downstream applications involving structure–activity mapping through x-ray crystallography or high-resolution MS, where the extra electron density from bromine aids in scattering, leading to better signal tracking in low-abundance peptides. For those familiar with labor-intensive efforts of isolating trace peptides, any chance to improve analytical visibility counts as a clear step forward.

    Safety considerations should not be overlooked. Brominated amino acids overall maintain a good profile in standard biochemical settings, though as with any compound, proper lab practice and personal protection remain critical. Current data show no red flags—unlike some halogenated reagents where toxicity may become an issue. This has built confidence among my peers who regularly introduce these analogues into cell culture or animal models.

    Considerations for Usage and Handling

    Practical experience over many projects has honed my approach to using unusual amino acids. 6-Bromoxytryptophan works well in both peptide assembly and larger protein engineering projects, as it resists racemization and solubilizes well in common solvents like DMSO, DMF, or water, depending on the protocol. Extended storage at room temperature does not cause rapid breakdown, so researchers do not find themselves discarding expensive reagents mid-project. Peptide bond formation follows a similar route as with standard tryptophan, thus avoiding the headaches brought on by less compatible analogues.

    The bromine substitution rarely poses problems in solid-phase peptide synthesis (SPPS), either, so this compound fits straight into established workflows. For anyone accustomed to troubleshooting coupling inefficiency with other halogenated amino acids, the reliability here feels refreshing. Cleanup and purification do not require extra steps, since brominated by-products are generally soluble and can be separated by standard reverse-phase HPLC. Those who plan downstream modification using the bromine handle will appreciate the straightforward reactivity, which opens doors in late-stage functionalization without tedious protocol changes.

    Product packaging has shifted with the times, too. No longer does ordering a sensitive amino acid mean bracing for poorly sealed glass. Modern suppliers send 6-Bromoxytryptophan in airtight, dark plastic jars or high-grade foil pouches that block light and moisture. In the old setup, chemical degradation from humidity or UV meant ruined batches. Savvy procurement managers take note of companies known for tight quality control and transparent batch testing; the peace of mind translates directly into project success rates.

    Applications in Research and Commercial Development

    The landscape of peptide therapeutics and protein-enhanced research tools keeps changing, with engineered building blocks like 6-Bromoxytryptophan playing a larger role. In the field of drug discovery, brominated tryptophan derivatives sometimes help pharma teams develop peptides that resist enzymatic breakdown, which can extend half-life or tweak in vivo performance. By altering interaction patterns in receptor sites, bromine-substituted residues can fine-tune biological activity—sometimes transforming an inert template into a promising lead compound.

    Peptide mapping studies stand to benefit too, especially in projects where researchers want to block or highlight a particular active site. Brominated tryptophan analogs have made it easier to pinpoint and confirm functional importance through site-directed mutagenesis or photoaffinity crosslinking. In the competitive world of protein structure work, these chemical handles have cemented their place by enabling clear and reproducible data while requiring little method development.

    Outside high-end research, biotechnologists experiment with incorporating 6-Bromoxytryptophan into enzymes or antibody fragments as a way of imparting new chemical properties. As industrial biotech gears up for more robust catalysts or novel biosensors, the flexibility gained by including such chemical tools cannot be overstated. In my view, tinkering with nature’s toolkit using selective amino acid analogues like this signals a maturity in synthetic biology—no longer just following biological blueprints but writing new ones.

    Perspectives on Broader Impact

    It’s not hard to find excitement over halogenated amino acids among protein engineers, but the influence of 6-Bromoxytryptophan stretches further than the lab bench. Analytical chemists gain traces that are easier to follow, while synthetic organic chemists appreciate the clean reactivity and well-understood substitution chemistry. Educators running advanced undergraduate or graduate courses in chemical biology sometimes build real-world research modules around the use of these rare amino acids, giving students a glimpse of problems that academic papers too often gloss over.

    Colleagues active in the neuropharmacology space have told me that integrating such modified amino acids in brain protein studies helps decode elusive signaling events. For instance, replacing natural tryptophan with a brominated version can show subtle shifts in receptor behavior that pure theory or computational work tends to miss. Where high-throughput screening has failed, careful use of distinctive chemical markers found in analogues like 6-Bromoxytryptophan bridges the gap, highlighting rare or low-abundance binding events.

    There’s hope that sustained work with derivatives such as this can boost global drug development and diagnostic innovation. By broadening the types of amino acids available to scientists, exploratory targets—be they novel enzymes, biosensor elements, or targeted peptides—become easier to reach. Sourcing high-quality, reliable material supports reproducibility and supports the kinds of collaborations that drive faster cycles of discovery.

    Ethics, Transparency, and Sourcing

    In recent years, greater emphasis on transparency has led to improvements in sourcing, testing, and batch validation for specialty amino acids. Projects funded by major institutions now require traceable supply chains and full disclosure about the origins of chemical building blocks. Researchers are increasingly asking about third-party purity certificates, contamination reports, and the presence of racemization or unusual byproducts. Such scrutiny drives producers of 6-Bromoxytryptophan to invest in better procedures—not only for purity but for long-term data integrity. For those of us who’ve experienced setbacks due to questionable reagents, these changes are nothing but positive.

    Onto the question of environmental and occupational safety: handling brominated compounds raises awareness about responsible disposal and worker protection, especially in bulk applications. Efforts to source from ethically run, environmentally conscious producers align with a growing movement in chemical procurement—one which ties practical lab work to broader social and environmental impacts.

    Navigating Price, Quality, and Research Outcomes

    In research-intensive fields, the up-front price of high-quality reagents sometimes sparks debate. Is the cost of 6-Bromoxytryptophan justified by its advantages? In my view, the long-term savings in reliability, time, and analytic clarity far outweigh any hesitation. On the rare occasion that a project encountered unexplained inconsistencies, a review of chemical supply or batch quality often identified the culprit: poorly characterized analogues from less reputable sources. Teams that prioritize tight sourcing standards minimize the risk of reproducibility problems and wasted resources.

    For graduate students or early-career scientists, gaining experience with 6-Bromoxytryptophan introduces both technical skill and an appreciation for the balance between innovation and practicality. Supervisors who encourage thoughtful trial and error with new amino acid derivatives often see their teams build confidence in experimental troubleshooting. Such culture change smooths transitions from academic projects to industrial R&D.

    Innovation Opportunities and Future Directions

    Innovation in polypeptide and protein chemistry continues to surge, with demand rising for unique functional groups that expand what can be built from biological templates. 6-Bromoxytryptophan, as a chemically active and reliable tool, supports this growth. Teams invested in combinatorial chemistry, peptide therapeutics, or bioengineering focus more attention now on analogues with functional handles—an area where the bromine tag can anchor a whole family of reactions. As researchers gain access to libraries of site-selectively modified peptides, the list of downstream applications widens.

    Sophisticated techniques like bioconjugation, advanced imaging, or even fragment-based drug discovery stand to benefit from the presence of halogen tags. 6-Bromoxytryptophan may appear as one entry in a crowded field, but its favorable mix of stability, reactivity, and compatibility with common protocols sets it apart from both older and more exotic analogues.

    Imagining Solutions and Next Steps

    For those aiming to get the best from 6-Bromoxytryptophan, a few paths stand out. Institutions and labs that invest in staff training around new reagent handling stay agile during unexpected setbacks. Open sharing of methods and results among researchers encourages the rapid spread of new protocols. Journals can help by inviting deeper discussions of both the setbacks and breakthroughs that come from working with analogues. Collaboration with suppliers to push for ever-higher purity and clearer chemical characterization will ensure product consistency for sensitive applications.

    On a broader level, building multidisciplinary teams—combining expertise in chemistry, molecular biology, and analytical science—makes it easier to solve tough problems. As biologists raise questions about protein dynamics or target engagement, chemists with experience in halogenated amino acids like 6-Bromoxytryptophan create the tools for answers. New generations of scientists will find in these compounds a bridge into flexible, solution-oriented discovery.

    Reflecting on the overall direction in research, I see 6-Bromoxytryptophan not merely as a single new widget but as evidence of how far amino acid engineering has come. It signals a movement away from following fixed patterns toward shaping chemistry that meets precise research needs. As open data and honest discussion become the norm, tools like this will continue to empower thoughtful, evidence-driven science.